Novel type of renal amyloidosis derived from apolipoprotein-CII

Journal of the American Society of Nephrology

Volumn 28, Issue 2, 2017, Pages 439-445

  Nasr, Samih H ^a   Dasari, Surendra ^a   Hasadsri, Linda ^a   Theis, Jason D ^a   Vrana, Julie A ^a   Gertz, Morie A ^a   Muppa, Prasuna ^a   Zimmermann, Michael T ^a   Grogg, Karen L ^a   Dispenzieri, Angela ^a   Sethi, Sanjeev ^a   Highsmith, W Edward ^a   Merlini, Giampaolo ^b   Leung, Nelson ^a   Kurtin, Paul J ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF PAVIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; APOLIPOPROTEIN C2; CHOLESTEROL; CONGO RED; CREATININE; GLUTAMIC ACID; HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN LIGHT CHAIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; M PROTEIN; SERUM ALBUMIN; TRIACYLGLYCEROL; VALINE;

ADULT; ALBUMIN BLOOD LEVEL; AMINO ACID SUBSTITUTION; ARTICLE; CASE REPORT; CHOLESTEROL BLOOD LEVEL; CREATININE BLOOD LEVEL; DNA SEQUENCE; FEMALE; GLOMERULUS; HEMOGLOBIN BLOOD LEVEL; HETEROZYGOSITY; HISTOPATHOLOGY; HUMAN; HYPERTENSION; HYPOTHYROIDISM; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; KIDNEY AMYLOIDOSIS; KIDNEY BIOPSY; KIDNEY FAILURE; KIDNEY INTERSTITIUM; LASER MICRODISSECTION; LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY; MIDDLE AGED; MOLECULAR DYNAMICS; NEPHROTIC SYNDROME; PERIPHERAL EDEMA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FOLDING; PROTEOMICS; TRIACYLGLYCEROL BLOOD LEVEL; AMYLOIDOSIS; CLASSIFICATION; KIDNEY DISEASES; PHYSIOLOGY;

AMYLOIDOSIS; APOLIPOPROTEIN C-II; FEMALE; HUMANS; KIDNEY DISEASES; MIDDLE AGED;

EID: 85016439246     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2015111228     Document Type: Article

References (30)

1. Sipe JD, Benson MD, Buxbaum JN, Ikeda S, Merlini G, Saraiva MJ, Westermark P: Nomenclature 2014: Amyloid fibril proteins and clinical classification of the amyloidosis. Amyloid 21: 221-224, 2014
2. de Carvalho M, Linke RP, Domingos F, Evangelista T, Ducla-Soares JL, NathrathWB, Azevedo-Coutinho C, Lima R, Saraiva MJ: Mutant fibrinogen A-alpha-chain associated with hereditary renal amyloidosis and peripheral neuropathy. Amyloid 11: 200-207, 2004
3. Haagsma EB, Hawkins PN, Benson MD, Lachmann HJ, Bybee A, Hazenberg BP: Familial amyloidotic polyneuropathy with severe renal involvement in associationwith transthyretin Gly47Glu in Dutch, British and American-Finnish families. Amyloid 11: 44-49, 2004
4. Rowczenio D, Tennent GA, Gilbertson J, Lachmann HJ, Hutt DF, Bybee A, Hawkins PN, Gillmore JD: Clinical characteristics and SAP scintigraphic findings in 10 patients with AGel amyloidosis. Amyloid 21: 276-281, 2014
5. Sattianayagam PT, Gibbs SD, Rowczenio D, Pinney JH, Wechalekar AD, Gilbertson JA, Hawkins PN, Lachmann HJ, Gillmore JD: Hereditary lysozyme amyloidosis - phenotypic heterogeneity and the role of solid organ transplantation. J InternMed272: 36-44, 2012
6. Vigushin DM, Gough J, Allan D, Alguacil A, Penner B, Pettigrew NM, Quinonez G, Bernstein K, Booth SE, Booth DR, Soutar, AK, Hawkins PN, Pepys, MB: Familial nephropathic systemic amyloidosis caused by apolipoprotein AI variant Arg26. Q J Med 87: 149-154, 1994
7. Yazaki M, Liepnieks JJ, BaratsMS, CohenAH, BensonMD:Hereditary systemic amyloidosis associated with a new apolipoprotein AII stop codon mutation Stop78Arg. Kidney Int 64: 11-16, 2003
8. Sethi S, Theis JD, Shiller SM, Nast CC, Harrison D, Rennke HG, Vrana JA, Dogan A: Medullary amyloidosis associated with apolipoprotein A-IV deposition. Kidney Int 81: 201-206, 2012
9. Said SM, Sethi S, Valeri AM, Leung N, Cornell LD, Fidler ME, Herrera Hernandez L, Vrana JA, Theis JD, Quint PS, Dogan A, Nasr SH: Renal amyloidosis: Origin and clinicopathologic correlations of 474 recent cases. Clin J Am Soc Nephrol 8: 1515-1523, 2013
10. Vrana JA, Theis JD, Dasari S, Mereuta OM, Dispenzieri A, Zeldenrust SR, Gertz MA, Kurtin PJ, Grogg KL, Dogan A: Clinical diagnosis and typing of systemic amyloidosis in subcutaneous fat aspirates by mass spectrometry-basedproteomics. Haematologica 99: 1239-1247, 2014
11. Dasari S, Theis JD, Vrana JA, Zenka RM, Zimmermann MT, Kocher JP, Highsmith WE Jr, Kurtin PJ, Dogan A: Clinical proteome informatics workbench detects pathogenic mutations in hereditary amyloidoses. J Proteome Res 13: 2352-2358, 2014
12. Verine J, Mourad N, Desseaux K, Vanhille P, Noël LH, Beaufils H, GrateauG, Janin A, Droz D: Clinical and histological characteristics of renal AA amyloidosis: A retrospective study of 68 cases with a special interest to amyloidassociated inflammatory response. Hum Pathol 38: 1798-1809, 2007
13. Kinnunen PK, Jackson RL, Smith LC, Gotto AM Jr, Sparrow JT: Activation of lipoprotein lipase by native and synthetic fragments of human plasma apolipoprotein C-II. Proc Natl Acad Sci U S A 74: 4848-4851, 1977
14. Baggio G, Manzato E, Gabelli C, Fellin R, Martini S, Enzi GB, Verlato F, Baiocchi MR, Sprecher DL, Kashyap ML: Apolipoprotein C-II deficiency syndrome. Clinical features, lipoprotein characterization, lipase activity, and correction of hypertriglyceridemia after apolipoprotein C-II administration in two affected patients. J Clin Invest 77: 520-527, 1986
15. BreckenridgeWC, Little JA, Steiner G, Chow A, Poapst M: Hypertriglyceridemia associatedwith deficiency of apolipoprotein C-II. N Engl J Med 298: 1265-1273, 1978
16. Hatters DM, MacPhee CE, Lawrence LJ, SawyerWH, Howlett GJ:Humanapolipoprotein C-II forms twisted amyloid ribbons and closed loops. Biochemistry 39: 8276-8283, 2000
17. Ryan TM, Teoh CL, Griffin MD, Bailey MF, Schuck P, HowlettGJ: Phospholipids enhance nucleation but not elongation of apolipoprotein C-II amyloidfibrils. JMolBiol399: 731-740, 2010
18. Lindgren M, Hammarström P: Amyloid oligomers: Spectroscopic characterization of amyloidogenic protein states. FEBS J 277: 1380-1388, 2010
19. Teoh CL, Pham CL, Todorova N, Hung A, Lincoln CN, Lees E, Lam YH, Binger KJ, Thomson NH, Radford SE, Smith TA, Müller SA, Engel A, Griffin MD, Yarovsky I, Gooley PR, Howlett GJ: A structural model for apolipoprotein C-II amyloid fibrils: Experimental characterization and molecular dynamics simulations. J Mol Biol 405: 1246-1266, 2011
20. Ryan TM, Mok YF, Howlett GJ, Griffin MD: The Role of Lipid in Misfolding and Amyloid Fibril Formation by Apolipoprotein C-II. Adv Exp Med Biol 855: 157-174, 2015
21. Legge FS, Treutlein H, Howlett GJ, Yarovsky I: Molecular dynamics simulations of a fibrillogenic peptide derived from apolipoprotein C-II. Biophys Chem 130: 102-113, 2007
22. Todorova N, Hung A, Maaser SM, Griffin MD, Karas J, Howlett GJ, Yarovsky I: Effects of mutation on the amyloidogenic propensity of apolipoprotein C-II(60-70) peptide. Phys Chem Chem Phys 12: 14762-14774, 2010
23. Mao Y, Zlatic CO, Griffin MD, Howlett GJ, Todorova N, Yarovsky I, Gooley PR: Hydrogen/Deuterium Exchange and Molecular Dynamics Analysis of Amyloid Fibrils Formed by a D69K Charge-Pair Mutant of Human Apolipoprotein C-II. Biochemistry 54: 4805-4814, 2015
24. Vrana JA, Gamez JD, Madden BJ, Theis JD, Bergen HR 3rd, Dogan A: Classification of amyloidosis by laser microdissection and mass spectrometry-based proteomic analysis in clinical biopsy specimens. Blood 114: 4957-4959, 2009
25. Theis JD, Dasari S, Vrana JA, Kurtin PJ, Dogan A: Shotgun-proteomics-based clinical testing for diagnosis and classification of amyloidosis. J Mass Spectrom 48: 1067-1077, 2013
26. Phillips JC, Braun R, Wang W, Gumbart J, Tajkhorshid E, Villa E, Chipot C, Skeel RD, Kalé L, Schulten K: Scalablemolecular dynamicswith NAMD. J Comput Chem26: 1781-1802, 2005
27. Mackerell AD Jr, Feig M, Brooks CL 3rd: Extending the treatment of backbone energetics in protein force fields: Limitations of gas-phase quantum mechanics in reproducing protein conformational distributions in molecular dynamics simulations. J Comput Chem 25: 1400-1415, 2004
28. MacRaild CA, Howlett GJ, Gooley PR: The structure and interactions of human apolipoprotein C-II in dodecyl phosphocholine. Biochemistry 43: 8084-8093, 2004
29. Grant BJ, Rodrigues AP, ElSawy KM, McCammon JA, Caves LS: Bio3d: An R package for the comparative analysis of protein structures. Bioinformatics 22: 2695-2696, 2006
30. Humphrey W, Dalke A, Schulten K: VMD: Visual molecular dynamics. J Mol Graph 14: 27-38, 1996.